Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Palindrome vs. BioFlo DuraMax Hemodialysis Catheters: A Prospective Randomized Trial

NCT02796300 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT02796300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02796300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Palindrome vs. BioFlo DuraMax Hemodialysis Catheters: A Prospective Randomized Trial
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Terminated
Start date
January 20, 2017
Completion date
June 25, 2019
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease